194 related articles for article (PubMed ID: 9933692)
21. Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene.
Nawrocki B; Polette M; Burlet H; Birembaut P; Adnet JJ
J Bone Miner Res; 1999 Feb; 14(2):288-94. PubMed ID: 9933484
[TBL] [Abstract][Full Text] [Related]
22. Coordinated and cell-specific regulation of membrane type matrix metalloproteinase 1 (MT1-MMP) and its substrate matrix metalloproteinase 2 (MMP-2) by physiological signals during follicular development and ovulation.
Liu K; Wahlberg P; Ny T
Endocrinology; 1998 Nov; 139(11):4735-8. PubMed ID: 9794486
[TBL] [Abstract][Full Text] [Related]
23. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum.
Liu K; Olofsson JI; Wahlberg P; Ny T
Endocrinology; 1999 Nov; 140(11):5330-8. PubMed ID: 10537164
[TBL] [Abstract][Full Text] [Related]
24. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
Knäuper V; Will H; López-Otin C; Smith B; Atkinson SJ; Stanton H; Hembry RM; Murphy G
J Biol Chem; 1996 Jul; 271(29):17124-31. PubMed ID: 8663255
[TBL] [Abstract][Full Text] [Related]
25. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
Sato H; Okada Y; Seiki M
Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
[TBL] [Abstract][Full Text] [Related]
26. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms for pro matrix metalloproteinase activation.
Murphy G; Stanton H; Cowell S; Butler G; Knäuper V; Atkinson S; Gavrilovic J
APMIS; 1999 Jan; 107(1):38-44. PubMed ID: 10190278
[TBL] [Abstract][Full Text] [Related]
28. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
29. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
[TBL] [Abstract][Full Text] [Related]
31. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
[TBL] [Abstract][Full Text] [Related]
32. Stromal fibroblasts adjacent to invasive thyroid tumors: expression of gelatinase A but not stromelysin 3 mRNA.
Zedenius J; Ståhle-Bäckdahl M; Enberg U; Grimelius L; Larsson C; Wallin G; Bäckdahl M
World J Surg; 1996 Jan; 20(1):101-6. PubMed ID: 8588399
[TBL] [Abstract][Full Text] [Related]
33. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.
Parsons SL; Watson SA; Collins HM; Griffin NR; Clarke PA; Steele RJ
Br J Cancer; 1998 Dec; 78(11):1495-502. PubMed ID: 9836483
[TBL] [Abstract][Full Text] [Related]
34. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
[TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
[TBL] [Abstract][Full Text] [Related]
37. Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells.
Polette M; Gilles C; Marchand V; Seiki M; Tournier JM; Birembaut P
Clin Exp Metastasis; 1997 Mar; 15(2):157-63. PubMed ID: 9062392
[TBL] [Abstract][Full Text] [Related]
38. Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas.
Harada T; Arii S; Mise M; Imamura T; Higashitsuji H; Furutani M; Niwano M; Ishigami S; Fukumoto M; Seiki M; Sato H; Imamura M
J Hepatol; 1998 Feb; 28(2):231-9. PubMed ID: 9514536
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
[TBL] [Abstract][Full Text] [Related]
40. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
